switching from semaglutide to tirzepatide results Switching from Semaglutide to Tirzepatide

These sources may market retatrutide alongside FDA-approved compounds like semaglutide and tirzepatide, sometimes implying a level of pharmaceutical oversight that does not actually exist for retatrutide as an investigational compound

Whilst effective in improving blood glucose control, emerging evidence links Ozempic and other GLP-1 agonists to an increased risk of gallbladder complications, including gallstones and cholecystitis

Weiser et al (2008)

To avoid frequent flip-flopping, we believe it is ethically justified for the FDA to require a greater burden of proof, or a greater level of certainty provided by the evidence at hand, to justify removal of a boxed warning than it did to impose one, they wrote

10.1001/archneurol.2011.70 Arch